Geron Corp reports results for the quarter ended December 31 - Earnings Summary

Geron

26/02/2025 14:32

Geron Corp GERN.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -9 cents.  The mean expectation of nine analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -7 cents to -2 cents per share.

Revenue rose 206,587% to $47.54 million from a year ago; analysts expected $45.66 million.

Geron Corp's reported EPS for the quarter was a loss of 4 cents​.

The company reported a quarterly loss of $25.35 million.

Geron Corp shares had fallen by 33.1% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 17.2% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Geron Corp is $8.00

This summary was machine generated from LSEG data February 26 at 02:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.05
-0.04
Beat
Sep. 30 2024
-0.08
-0.04
Beat
Jun. 30 2024
-0.10
-0.10
Met
Mar. 31 2024
-0.10
-0.09
Beat